Home/Oxford Biomedica/Dr. Frank Mathias
DF

Dr. Frank Mathias

Chief Executive Officer

Oxford Biomedica

Roles

Chief Executive OfficeratOxford Biomedica
Member of the Supervisory BoardatFormycon AG

Oxford Biomedica Pipeline

DrugIndicationPhase
Kymriah (Novartis) - LV Vector SupplyB-cell Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-Cell Lymphoma (DLBCL)Approved